Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Method
3.2. Market Snippet by Product
3.3. Market Snippet by Application
3.4. Market Snippet by End-Users
3.5. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing investment in life sciences industries
4.1.1.2. Rise in government funding
4.1.2. Restraints:
4.1.2.1. High degree of market consolidation
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Value Chain Analysis
5.4. PEST Analysis
5.5. Pricing Analysis
5.6. Regulatory Analysis
5.7. Reimbursement Analysis
5.8. Unmet Needs
5.9. Patent Trends
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Method
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method Segment
7.3. Market Attractiveness Index, By Method Segment
7.3.1. Solvent Detergent Method*
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3.2. Pasteurization
7.3.3. Others
8. By Product
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
8.3. Market Attractiveness Index, By Product Segment
8.3.1. Kits and Reagents*
8.3.1.1. Introduction
8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3.2. Services
8.3.3. Viral Inactivation Systems and Accessories
9. By Application
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
9.3. Market Attractiveness Index, By Application Segment
9.3.1. Vaccines and Therapeutics*
9.3.1.1. Introduction
9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
9.3.2. Blood and Blood Products
9.3.3. Cellular and Gene Therapy Products
9.3.4. Tissues and Tissue Products
9.3.5. Stem Cell Products
10. By End-Users
10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
10.3. Market Attractiveness Index, By End-Users
10.3.1. Pharmaceutical and Biotechnology Companies*
10.3.1.1. Introduction
10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
10.3.2. Contract Research Organizations
10.3.3. Others
11. By Region
11.1. Introduction
11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
11.3. Market Attractiveness Index, By Region
11.4. North America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. U.S.
11.4.7.2. Canada
11.4.7.3. Mexico
11.5. Europe
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. Germany
11.5.7.2. U.K.
11.5.7.3. France
11.5.7.4. Italy
11.5.7.5. Spain
11.5.7.6. Rest of Europe
11.6. South America
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
11.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.6.7.1. Brazil
11.6.7.2. Argentina
11.6.7.3. Rest of South America
11.7. Asia Pacific
11.7.1. Introduction
11.7.2. Key Region-Specific Dynamics
11.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
11.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
11.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
11.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.7.7.1. China
11.7.7.2. India
11.7.7.3. Japan
11.7.7.4. Australia
11.7.7.5. Rest of Asia Pacific
11.8. Middle East and Africa
11.8.1. Introduction
11.8.2. Key Region-Specific Dynamics
11.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
11.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
11.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
11.8.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Charles River Laboratories International, Inc.*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Clean Cells Inc.
13.3. Danaher Corporation
13.4. Cerus Corporation
13.5. Parker Hannifin Corporation
13.6. Merck KGaA
13.7. Rad Source Technologies, Inc.
13.8. Sartorius AG
13.9. SGS SA
13.10. Wuxi Pharmatech (Cayman) Inc.
13.11. Bioteke Corporation
13.12. Hangzhou Qijulongyuan Medical Equipment
13.13. Shenzhen Zijian Biotechnology Co., Ltd.
13.14. Guangdong Poctman Life Technology Co., Ltd. (List Not Exhaustive)
14. Premium Insights
15. DataM Intelligence
15.1. Appendix
15.2. About Us and Services
15.3. Contact Us